Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRImus-AD
NCT06182085Phase 2Completed
- Sponsor
- PRInnovation GmbH
- Start
- Feb 2024
- Primary completion
- Apr 2026
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of PRI-002 in Alzheimer's disease (AD), sponsored by PRInnovation GmbH. Started Feb 2024; status: completed.
02
Drugs
PRI-002
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06182085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06182085.